Adil I Daud Selected Research

polyglutamate camptothecin

10/2007

Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adil I Daud Research Topics

Disease

40	Melanoma (Melanoma, Malignant) 01/2022 - 01/2006
36	Neoplasms (Cancer) 01/2022 - 12/2005
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2008
3	Skin Neoplasms (Skin Cancer) 01/2022 - 12/2019
3	Breast Neoplasms (Breast Cancer) 12/2005 - 05/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2008
2	Merkel Cell Carcinoma 01/2020 - 01/2018
2	Disease Progression 01/2018 - 11/2014
2	Fatigue 03/2015 - 02/2012
2	Thrombocytopenia (Thrombopenia) 03/2015 - 12/2011
2	Nausea 03/2015 - 02/2012
2	Necrosis 12/2008 - 11/2008
1	Inflammation (Inflammations) 01/2020
1	Uveal melanoma 11/2016
1	Constipation 03/2015
1	Neutropenia 03/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2014
1	Pigmented Nevus (Melanocytic Nevus) 11/2014
1	Sarcoma (Soft Tissue Sarcoma) 03/2013
1	Vomiting 02/2012
1	Exanthema (Rash) 02/2012
1	Anorexia 02/2012
1	Diarrhea 02/2012
1	Myocardial Infarction 12/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2008
1	Lymphoma (Lymphomas) 11/2008

Drug/Important Bio-Agent (IBA)

6	pembrolizumabIBA 01/2022 - 01/2016
6	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2015
6	Interleukin-12 (IL 12)IBA 01/2022 - 12/2008
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2005
4	IpilimumabIBA 01/2021 - 10/2015
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2006
4	LigandsIBA 01/2017 - 01/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020 - 03/2013
3	AntibodiesIBA 11/2016 - 01/2014
3	Valproic Acid (Depakote)FDA LinkGeneric 11/2011 - 12/2005
2	VaccinesIBA 01/2022 - 01/2006
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 04/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2018
2	AntigensIBA 01/2020 - 01/2019
2	CytokinesIBA 12/2018 - 01/2018
2	CTLA-4 AntigenIBA 01/2017 - 01/2016
2	NivolumabIBA 01/2016 - 10/2015
2	bosutinibIBA 02/2012 - 06/2009
2	Interleukin-2 (IL2)IBA 12/2011 - 08/2010
2	Peptides (Polypeptides)IBA 12/2011 - 01/2006
2	cositecanIBA 11/2011 - 04/2009
2	Topoisomerase I InhibitorsIBA 11/2011 - 04/2009
2	Histone Deacetylase InhibitorsIBA 11/2011 - 04/2009
2	Histones (Histone)IBA 12/2005 - 05/2005
2	Topoisomerase II InhibitorsIBA 12/2005 - 12/2005
1	NexusIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	dabrafenibIBA 10/2020
1	trametinibIBA 10/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 12/2018
1	HLA-DR Antigens (HLA-DR)IBA 11/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2017
1	B7-H1 AntigenIBA 12/2016
1	Death Domain ReceptorsIBA 11/2016
1	MK-8776IBA 03/2015
1	Gemcitabine FDA Link 03/2015
1	Checkpoint Kinase 1IBA 03/2015
1	VemurafenibIBA 11/2014
1	cobimetinibIBA 11/2014
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 03/2013
1	Mitogen-Activated Protein KinasesIBA 03/2013
1	Growth Factor ReceptorsIBA 03/2013
1	TOR Serine-Threonine KinasesIBA 03/2013
1	Phosphotransferases (Kinase)IBA 02/2012
1	Tyrosine Kinase InhibitorsIBA 02/2012
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	HLA-A*02:01 antigenIBA 12/2011
1	Tumor Suppressor Protein p53IBA 12/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2011
1	EpitopesIBA 12/2011
1	ALT-801IBA 12/2011
1	CamptothecinIBA 11/2011
1	Bevacizumab (Avastin)FDA Link 01/2011
1	Sunitinib (Sutent)FDA Link 01/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2009
1	Dasatinib (BMS 354825)FDA Link 06/2009
1	Platinum Compounds (Compounds, Platinum)IBA 06/2009
1	Temozolomide (Temodar)FDA LinkGeneric 06/2009
1	PhosphotyrosineIBA 06/2009
1	Cisplatin (Platino)FDA LinkGeneric 06/2009
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2009
1	InterleukinsIBA 12/2008
1	sepantroniumIBA 11/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2008

Therapy/Procedure

26	Therapeutics 01/2022 - 07/2007
19	Immunotherapy 01/2022 - 01/2006
6	Drug Therapy (Chemotherapy) 01/2017 - 07/2006
1	Injections 01/2020
1	Radiotherapy 01/2018
1	Electrodes (Electrode) 12/2008
1	Intravenous Infusions 11/2008